Simple & Efficient Protocol for Native Chromatin Immunoprecipitation

porvairpr440-image

Chromatrap, a business unit of Porvair Sciences, announces a new patented protocol that is able to simply, quickly and efficiently enrich transcription factors from Native Chromatin.

Native Chromatin Immunoprecipitation (N-ChIP) is an alternative to traditional cross-linked (X-ChIP), which removes the need for fixing cells with formaldehyde prior to extraction. As a consequence the cells remain in a more natural 'native state'. The DNA/protein fragments are selectively immunoprecipitated using antibodies directed against the protein of interest and the resulting fractions treated to separate the DNA and protein components. Native ChIP is the technique of choice for the study of histone modifiers and certain abundant transcription factors that are likely to be bound to DNA.

Traditionally Native ChIP assays have involved five key time-consuming steps: Preparation of chromatin to be analyzed from cells ; Immunoprecipitation of chromatin using a high quality ChIP-validated antibody specific to the target protein ; isolation of the precipitated chromatin fragments ; DNA recovery from the precipitated product and finally DNA analysis.

The Chromatrap® N-ChIP kit provides a new quicker, easier and more efficient way of performing N-ChIP assays (Patent No. GB2482209). It uses discs of an inert, porous, polymer to which Protein A or Protein G has been covalently attached to maximize the capture efficiency of the target chromatin/antibody complex.

Unlike other approaches the Chromatrap® N-ChIP kit eliminates using agarose or magnetic beads resulting in more sample being retained during the extraction process. In addition Chromatrap® N-ChIP technology increases the affinity of antibody binding to antigens on Native chromatin as peptides are more accessible. As a result the Chromatrap® N-ChIP kit sets a new standard for enriching transcription factors from Native Chromatin.

Source: Chromatrap

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Chromatrap® - Porvair Sciences Ltd. (2017, August 03). Simple & Efficient Protocol for Native Chromatin Immunoprecipitation. News-Medical. Retrieved on November 21, 2024 from https://www.news-medical.net/news/20160122/Simple-Efficient-Protocol-for-Native-Chromatin-Immunoprecipitation.aspx.

  • MLA

    Chromatrap® - Porvair Sciences Ltd. "Simple & Efficient Protocol for Native Chromatin Immunoprecipitation". News-Medical. 21 November 2024. <https://www.news-medical.net/news/20160122/Simple-Efficient-Protocol-for-Native-Chromatin-Immunoprecipitation.aspx>.

  • Chicago

    Chromatrap® - Porvair Sciences Ltd. "Simple & Efficient Protocol for Native Chromatin Immunoprecipitation". News-Medical. https://www.news-medical.net/news/20160122/Simple-Efficient-Protocol-for-Native-Chromatin-Immunoprecipitation.aspx. (accessed November 21, 2024).

  • Harvard

    Chromatrap® - Porvair Sciences Ltd. 2017. Simple & Efficient Protocol for Native Chromatin Immunoprecipitation. News-Medical, viewed 21 November 2024, https://www.news-medical.net/news/20160122/Simple-Efficient-Protocol-for-Native-Chromatin-Immunoprecipitation.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Ovarian cancer project shows promise